Ming-Lung Yu, Ph.D.

Senior Vice President

Contact：

TEL：07-5252010

Email：fish6069@gmail.com

現職：

國立中山大學副校長(2022/8迄今)
國立中山大學醫學院院長(2022/8迄今)
高雄醫學大學/講座教授(2020/8迄今)
高雄醫學大學附設紀念醫院肝膽胰內科/主治醫師(1994/8迄今)

Education：

高雄醫學大學/醫學研究所/博士(2000畢)

專長：

病毒性肝炎、肝癌、脂肪肝、轉譯醫學

Executive Experiences：

高雄醫學大學/特聘教授(2013-2020)
國立陽明交通大學/生物科技學院/客座教授(2017-2021)
高雄醫學大學/副校長(2018-2021)
國立中山大學/名譽講座教授(2020-2022)
高雄市立大同醫院院長(2010-2012)
高雄醫學大學附設紀念醫院/副院長(2012-2015)
高雄醫學大學附設紀念醫院/肝膽胰內科/肝炎防治中心/主任(2015-2016)
美國馬薩諸塞州波士頓哈佛醫學院/馬薩諸塞州總醫院/消化內科肝臟中心/客座教授(2016-2017)
高雄醫學大學/肝炎研究中心/主任(2019-2022)
高雄醫學大學附設紀念醫院/人體試驗委員會/主任委員(2021-2022)
高雄醫學大學/人體生物資料庫/主任委員(2021-2022)

Honors and Awards:

2022 Outstanding Abstract Award of APASL STC (Asian Pacific Association for the Study of the Liver Single Topic Conference) on HCC 2022
2022 The Presidential Award of APASL STC (Asian Pacific Association for the Study of the Liver Single Topic Conference) on HCC 2022
2021 Awardee of APASL(Asian Pacific Association for the Study of the Liver) on Oncology 2021 (Let-7a and Let-7i as biomarkers for CHC patients with HCC risk after anti-viral treatment)
2021 Top 2% Scientists in the world 2020 and 1996-2020
2021 Poster Distinction Award DDW(Digestive Disease Week) 2021
2021 Award for Outstanding Research Article, Kaohsiung Medical University, Taiwan, July, 2021 (Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV coinfection)
2021 Poster Distinction Award DDW(Digestive Disease Week) 2021 (Clinical Presentation and Patient‐Reported Outcomes in Patients With Chronic Viral Hepatitis: Data From The Global Liver Registry)
2021 Recognized as Worldwide Expertise in Hepacivirus, 2021; ranking 1st in Taiwan, 2nd in Asia
2021 Foreign Investigator Award, the Liver Week 2021 Virtual Conference, May 13-15
2020 Poster of Distinction, The Liver Meeting Digital Experience™ 2020 of the AASLD, Nov 13-16
2019 The 29th WANG MING-NING Award for Outstanding Contributions of Academic Research Achievements to the Development of Medical Science and Technology, National Health and National Society, Taiwan
2019 Poster of Distinction, Presidential Award, American Association for the Study of the Liver, Boston, US
2018 The Presidential Award – Oral Presentation, Single Topic Conference of the APASL in Taipei, June 22-24
2018 Outstanding Research Article Award, Kaohsiung Medical University, Taiwan
2010-2018 Best Research Performance Index Award, Kaohsiung Medical University, Taiwan
2012 Outstanding Research Award, National Science Council
2012 Kao-Xing Award, Kaohsiung Medical Association, Taiwan

Ming-Lung Yu, Ph.D.

Senior Vice President

Contact：

國立中山大學副校長(2022/8迄今)

國立中山大學醫學院院長(2022/8迄今)

高雄醫學大學/講座教授(2020/8迄今)

高雄醫學大學附設紀念醫院肝膽胰內科/主治醫師(1994/8迄今)

Education：

高雄醫學大學/醫學研究所/博士(2000畢)

專長：

病毒性肝炎、肝癌、脂肪肝、轉譯醫學

Executive Experiences：

高雄醫學大學/特聘教授(2013-2020)

國立陽明交通大學/生物科技學院/客座教授(2017-2021)

高雄醫學大學/副校長(2018-2021)

國立中山大學/名譽講座教授(2020-2022)

高雄市立大同醫院院長(2010-2012)

高雄醫學大學附設紀念醫院/副院長(2012-2015)

高雄醫學大學附設紀念醫院/肝膽胰內科/肝炎防治中心/主任(2015-2016)

美國馬薩諸塞州波士頓哈佛醫學院/馬薩諸塞州總醫院/消化內科肝臟中心/客座教授(2016-2017)

高雄醫學大學/肝炎研究中心/主任(2019-2022)

高雄醫學大學附設紀念醫院/人體試驗委員會/主任委員(2021-2022)

高雄醫學大學/人體生物資料庫/主任委員(2021-2022)

Honors and Awards:

2022 Outstanding Abstract Award of APASL STC (Asian Pacific Association for the Study of the Liver Single Topic Conference) on HCC 2022

2022 The Presidential Award of APASL STC (Asian Pacific Association for the Study of the Liver Single Topic Conference) on HCC 2022

2021 Awardee of APASL(Asian Pacific Association for the Study of the Liver) on Oncology 2021 (Let-7a and Let-7i as biomarkers for CHC patients with HCC risk after anti-viral treatment)

2021 Top 2% Scientists in the world 2020 and 1996-2020

2021 Poster Distinction Award DDW(Digestive Disease Week) 2021

2021 Award for Outstanding Research Article, Kaohsiung Medical University, Taiwan, July, 2021 (Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV coinfection)

2021 Poster Distinction Award DDW(Digestive Disease Week) 2021 (Clinical Presentation and Patient‐Reported Outcomes in Patients With Chronic Viral Hepatitis: Data From The Global Liver Registry)

2021 Recognized as Worldwide Expertise in Hepacivirus, 2021; ranking 1st in Taiwan, 2nd in Asia

2021 Foreign Investigator Award, the Liver Week 2021 Virtual Conference, May 13-15

2020 Poster of Distinction, The Liver Meeting Digital Experience™ 2020 of the AASLD, Nov 13-16

2019 The 29th WANG MING-NING Award for Outstanding Contributions of Academic Research Achievements to the Development of Medical Science and Technology, National Health and National Society, Taiwan

2019 Poster of Distinction, Presidential Award, American Association for the Study of the Liver, Boston, US

2018 The Presidential Award – Oral Presentation, Single Topic Conference of the APASL in Taipei, June 22-24

2018 Outstanding Research Article Award, Kaohsiung Medical University, Taiwan

2010-2018 Best Research Performance Index Award, Kaohsiung Medical University, Taiwan

2012 Outstanding Research Award, National Science Council

2012 Kao-Xing Award, Kaohsiung Medical Association, Taiwan